Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000243088 | SCV000313402 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Gene |
RCV001660340 | SCV001873805 | benign | not provided | 2018-10-25 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002278206 | SCV002565173 | benign | Ehlers-Danlos syndrome | 2022-04-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002374424 | SCV002683886 | benign | Cardiovascular phenotype | 2019-02-12 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome Diagnostics Laboratory, |
RCV000243088 | SCV001809129 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000243088 | SCV001956658 | benign | not specified | no assertion criteria provided | clinical testing |